The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial
Abstract
Background: Procedural results for percutaneous coronary intervention (PCI) in coronary vessels with chronic total occlusion (CTO) have improved in recent years, and PCI strategies have moved toward more complete revascularization with more liberal use of CTO-PCI. However, evidence evaluating CTO-PCI is limited to observational studies and small clinical trials. Methods: In this open-label, multicenter, randomized, noninferiority trial, PCI-eligible patients were assigned to receive either 1 of 2 strategies: PCI or no PCI for the qualifying de novo CTO lesion with the option for PCI of obstructive non-CTO lesions at the discretion of the operator. The primary end point was a composite of death, myocardial infarction, stroke, or any revascularization. Health-related quality of life was assessed at baseline and at 1, 6, 12, 24, and 36 months. Because of slow recruitment, the trial was stopped before completion of the 1284 planned enrollments. Results: Between March 2010 and September 2016, 834 patients were randomly assigned to the CTO-PCI (n=417) or no CTO-PCI (n=398) strategy. Among the patients assigned to the no CTO-PCI strategy, 78 (19.6%) crossed over to receive staged CTO-PCI within 3 days of randomization. The overall CTO-PCI success rate was 90.6%. Serious nonfatal complications associated with CTO-PCI occurred in 3 patients (1 stroke, 1 cardiac tamponade, and 1 patient with recurrent episodes of ventricular tachyarrhythmia induced by intracoronary thrombus). Approximately half of the patients in each group underwent PCI for an average of 1.3 non-CTO lesions, resulting in a comparable residual SYNTAX score (Synergy Between PCI With TAXUS and Cardiac Surgery; 3.7±5.4 versus 4.0±5.9, P =0.42) confined to non-CTO vessels. During a median follow-up of 4.0 years (interquartile range, 2.4 to 5.1 years), there was no significant difference between the CTO-PCI and the no CTO-PCI strategies in the incidence of the primary end point (22.3% versus 22.4%, hazard ratio, 1.03; 95% CI, 0.77 to 1.37; P =0.86). Both CTO-PCI and no CTO-PCI strategy were associated with significant improvements but without between-group differences in disease-specific health status that was sustained through 36 months. Conclusions: CTO-PCI was feasible with high success rates. There was no difference in the incidence of major adverse cardiovascular events with CTO-PCI versus no CTO-PCI, but the study was limited by low power for clinical end points and high crossover rates between groups. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01078051.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EQ-SD: a measure of health status from the EuroQol Group
Rabin, R., & Charro, F. D. (2001) · Annals of Medicine · doi:10.3109/07853890109002087 · Cited by 5,613
Serruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., van den Brand, M., Bass, E. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804626 · Cited by 4,331
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,410
Hachamovitch, R., Hayes, S. W., Friedman, J. D., Cohen, I., & Berman, D. S. (2003) · Circulation · doi:10.1161/01.cir.0000072790.23090.41 · Cited by 1,563
Spertus, J. A., Winder, J. A., Dewhurst, T. A., Deyo, R. A., Prodzinski, J., McDonnell, M., & Fihn, S. D. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00397-9 · Cited by 1,385
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000134 · Cited by 1,059
Current Perspectives on Coronary Chronic Total Occlusions
Fefer, P., Knudtson, M. L., Cheema, A. N., Galbraith, P. D., Osherov, A. B., Yalonetsky, S., Gannot, S., Samuel, M., Weisbrod, M., Bierstone, D., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.007 · Cited by 814
A Percutaneous Treatment Algorithm for Crossing Coronary Chronic Total Occlusions
Brilakis, E. S., Grantham, J. A., Rinfret, S., Wyman, R. M., Burke, M. N., Karmpaliotis, D., Lembo, N., Pershad, A., Kandzari, D. E., Buller, C. E., et al. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.02.006 · Cited by 634
Werner, G. S., Martin-Yuste, V., Hildick-Smith, D., Boudou, N., Sianos, G., Gelev, V., Rumoroso, J. R., Erglis, A., Christiansen, E. H., Escaned, J., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy220 · Cited by 581
Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention
Brilakis, E. S., Banerjee, S., Karmpaliotis, D., Lombardi, W. L., Tsai, T. T., Shunk, K. A., Kennedy, K. F., Spertus, J. A., Holmes, D. R., & Grantham, J. A. (2015) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.08.014 · Cited by 479
Cited by
2024 ESC Guidelines for the management of chronic coronary syndromes
Vrints, C., Andreotti, F., Koskinas, K. C., Rossello, X., Adamo, M., Ainslie, J., Banning, A. P., Budaj, A., Buechel, R. R., Chiariello, G. A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae177 · Cited by 2,774
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.006 · Cited by 1,558
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001038 · Cited by 829
Brilakis, E. S., Mashayekhi, K., Tsuchikane, E., Abi Rafeh, N., Alaswad, K., Araya, M., Avran, A., Azzalini, L., Babunashvili, A. M., Bayani, B., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.039797 · Cited by 456
Self-citation
Metadata
- Authors
- Lee, S.-W., Lee, P. H., Ahn, J.-M., Park, D.-W., Yun, S.-C., Han, S., Kang, H., Kang, S.-J., Kim, Y.-H., Lee, C. W., Park, S.-W., Hur, S. H., Rha, S.-W., Her, S.-H., Choi, S. W., Lee, B.-K., Lee, N.-H., Lee, J.-Y., Cheong, S.-S., Kim, M. H., Ahn, Y.-K., Lim, S. W., Lee, S.-G., Hiremath, S., Santoso, T., Udayachalerm, W., Cheng, J. J., Cohen, D. J., Muramatsu, T., Tsuchikane, E., Asakura, Y., & Park, S.-J.
- Venue
- Circulation
- Published
- 2019-04-02
- Volume
- 139
- Issue
- 14
- Pages
- 1674-1683
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2916496138
- Cited by
- 407
- References
- 21
- FWCI
- 41.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial. https://app.cochat.ai/papers/10.1161/circulationaha.118.031313
- The paper
- Lee, S.-W., Lee, P. H., Ahn, J.-M., Park, D.-W., Yun, S.-C., Han, S., Kang, H., Kang, S.-J., Kim, Y.-H., Lee, C. W., Park, S.-W., Hur, S. H., Rha, S.-W., Her, S.-H., Choi, S. W., Lee, B.-K., Lee, N.-H., Lee, J.-Y., Cheong, S.-S., . . . Park, S.-J. (2019). Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial. Circulation. https://doi.org/10.1161/circulationaha.118.031313
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.